Showing results (141-150 of 1,348) with videos related to

Sort By:
Pageof 135
Clinical Pharmacology in Drug Development|October 15, 2016
Safety, Tolerability, and Pharmacokinetics of ARC-520 Injection, an RNA Interference-Based Therapeutic for the Treatment of Chronic Hepatitis B Virus Infection, in Healthy VolunteersThomas Schluep, Jason Lickliter, James Hamilton, et al.
Clinical Pharmacology in Drug Development|October 15, 2016
Phase 1 and Pharmacokinetic Drug-Drug Interaction Study of Metformin, Losartan, and Linagliptin Coadministered With DW1029M in Healthy VolunteersSeol Ju Moon, Sun-Young Kim, Cheol-Hee Lim, et al.
Clinical Pharmacology in Drug Development|November 18, 2020
Population Pharmacokinetic Model for Ertugliflozin in Healthy Subjects and Patients With Type 2 Diabetes MellitusDaryl J Fediuk, Susan Zhou, Vikas Kumar Dawra, et al.
Clinical Pharmacology in Drug Development|November 8, 2019
The Influence of Renal or Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of OliceridineAnne N Nafziger, Kelly A Arscott, Kristina Cochrane, et al.
Clinical Pharmacology in Drug Development|February 23, 2020
Thorough QT/QTc Study Shows That a Novel 5-HT4 Receptor Partial Agonist Minesapride Has No Effect on QT ProlongationTatsuto Hamatani, Naoto Noda, Takeshi Takagaki, et al.
Clinical Pharmacology in Drug Development|January 22, 2020
A Phase 1, Randomized, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Subcutaneous Tezepelumab in Healthy Japanese MenKei Sakamoto, Shunji Matsuki, Shin Irie, et al.
Clinical Pharmacology in Drug Development|August 18, 2017
Selection of 12-Hour Sustained-Release Acetaminophen (Paracetamol) Formulation Through Comparison of Pharmacokinetic Profiles of 4 Sustained-Release Prototype Formulations and Standard Acetaminophen Formulation: An Open-Label, Randomized, Proof-of-Principle Pharmacokinetic StudyYong Yue, Dongzhou J Liu
Clinical Pharmacology in Drug Development|February 2, 2018
Pharmacokinetic Drug Interaction Study of Bazedoxifene and IbuprofenWilliam McKeand, Susan Baird-Bellaire, James Ermer, et al.
Clinical Pharmacology in Drug Development|May 13, 2022
Effects of CYP3A Inhibition, CYP3A Induction, and Gastric Acid Reduction on the Pharmacokinetics of Ripretinib, a Switch Control KIT Tyrosine Kinase InhibitorXiaoyan Li, Mark J Shelton, Jing Wang, et al.
Clinical Pharmacology in Drug Development|July 17, 2021
Pharmacokinetics and Bioequivalence of a Generic Fixed-Dose Combination Tablet of Metformin Hydrochloride/Vildagliptin Versus a Branded Product in Healthy Chinese Subjects Under Fed and Fasting ConditionsLiJun Ye, Bei Li, NengMing Ling, et al.
Pageof 135